Financhill
Sell
35

AQST Quote, Financials, Valuation and Earnings

Last price:
$5.98
Seasonality move :
-1.28%
Day range:
$5.84 - $6.05
52-week range:
$2.12 - $7.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.66x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
2.5M
1-year change:
69.6%
Market cap:
$729.6M
Revenue:
$57.6M
EPS (TTM):
-$0.70

Earnings Data

Next earnings date for AQST
Mar 04
2026
Most recent earnings per share
-$0.14
Missed by $0.03
(Nov 5/2025)
Consensus Estimate
-$0.11
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AQST Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/04/2026 Q4 $13.3M -- -- -$0.13 --
11/05/2025 Q3 $12.9M $12.8M -$0.14 -$0.11 -$0.03
08/11/2025 Q2 $11.3M $10M -$0.14 -$0.17 $0.04
05/06/2025 Q1 $12.2M $8.7M -$0.24 -$0.16 -$0.08
03/05/2025 Q4 $13.1M $11.9M -$0.19 -$0.13 -$0.05
11/04/2024 Q3 $12.7M $13.5M -$0.13 -$0.12 -$0.01
08/06/2024 Q2 $12.4M $20.1M -$0.03 -$0.11 $0.08
05/07/2024 Q1 $12.3M $12.1M -$0.17 -$0.10 -$0.07
03/05/2024 Q4 $11.6M $13.2M -$0.13 -$0.07 -$0.06
11/06/2023 Q3 -- -- -$0.03 -$0.11 $0.08
08/07/2023 Q2 -- -- -$0.10 -$0.12 $0.02
05/02/2023 Q1 -- -- $0.11 -$0.07 $0.18
03/07/2023 Q4 -- -- -$0.23 -$0.23 --
11/01/2022 Q3 -- -- -$0.23 -$0.24 $0.01
08/02/2022 Q2 -- -- -$0.36 -- --
05/03/2022 Q1 -- -- -$0.32 -$0.33 $0.01
03/08/2022 Q4 -- -- -$0.72 -$0.49 -$0.23
11/02/2021 Q3 -- -- -$0.37 -$0.47 $0.10
08/03/2021 Q2 -- -- -$0.33 -$0.44 $0.11
05/04/2021 Q1 -- -- -$0.41 -$0.43 $0.02
03/09/2021 Q4 -- -- -$0.60 -$0.53 -$0.07
11/04/2020 Q3 -- -- -$0.49 -$0.43 -$0.06
08/04/2020 Q2 -- -- -$0.07 -$0.44 $0.37
05/05/2020 Q1 -- -- -$0.49 -$0.48 -$0.01
03/12/2020 Q4 -- -- -$0.48 -$0.40 -$0.08
11/06/2019 Q3 -- -- -$0.74 -$0.72 -$0.03
08/07/2019 Q2 -- -- -- -$0.66 --
05/08/2019 Q1 -- -- -- -$0.49 --
03/14/2019 Q4 -- -- -- -$0.56 --
11/06/2018 Q3 -- -- -- -$0.34 --
09/04/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -- --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -- --
06/30/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --

Aquestive Therapeutics, Inc. Earnings Questions

  • How Much did Aquestive Therapeutics, Inc. Generate in Revenue Last Quarter?

    Aquestive Therapeutics, Inc. reported $12.8M worth of top line sales in its most recent quarter.

  • Did Aquestive Therapeutics, Inc. Beat Earnings Last Quarter?

    Aquestive Therapeutics, Inc. announced earnings per share of -$0.14 which represents a miss of analyst forecast a -$0.11 per share.

  • Is Aquestive Therapeutics, Inc. Profitable?

    Aquestive Therapeutics, Inc. reported $8.3M that represents $0.08 per share over the last quarter.

  • What is the Analyst Consensus for Aquestive Therapeutics, Inc. EPS Next Year?

    Aquestive Therapeutics, Inc.'s earnings are forecast to decrease from -$0.51 per share to -$0.42 per share next year representing a decrease of -12.66%.

  • When is Aquestive Therapeutics, Inc.'s Earnings Date?

    Aquestive Therapeutics, Inc.'s next earnings date is March 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock